|
1
|
Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease.
|
Circulation
|
2002
|
1.58
|
|
2
|
IgG from patients with pulmonary arterial hypertension and/or systemic sclerosis binds to vascular smooth muscle cells and induces cell contraction.
|
Ann Rheum Dis
|
2011
|
1.53
|
|
3
|
Proteinase 3 on apoptotic cells disrupts immune silencing in autoimmune vasculitis.
|
J Clin Invest
|
2015
|
1.43
|
|
4
|
Changes in glycation and oxidation markers in patients starting peritoneal dialysis: a pilot study.
|
Perit Dial Int
|
2006
|
1.43
|
|
5
|
Advanced oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients.
|
Am J Kidney Dis
|
2005
|
1.15
|
|
6
|
Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3.
|
J Biol Chem
|
2007
|
1.10
|
|
7
|
Biochemical and spectrophotometric significance of advanced oxidized protein products.
|
Biochim Biophys Acta
|
2004
|
1.10
|
|
8
|
The role of neutrophils and monocytes in innate immunity.
|
Contrib Microbiol
|
2008
|
1.06
|
|
9
|
In cystic fibrosis homozygotes and heterozygotes, neutrophil apoptosis is delayed and modulated by diamide or roscovitine: evidence for an innate neutrophil disturbance.
|
J Innate Immun
|
2010
|
1.05
|
|
10
|
Respective role of uraemic toxins and myeloperoxidase in the uraemic state.
|
Nephrol Dial Transplant
|
2006
|
1.01
|
|
11
|
Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis.
|
Blood
|
2007
|
0.98
|
|
12
|
Inspection of the binding sites of proteinase3 for the design of a highly specific substrate.
|
J Med Chem
|
2006
|
0.95
|
|
13
|
Early prediction of IgA nephropathy progression: proteinuria and AOPP are strong prognostic markers.
|
Kidney Int
|
2004
|
0.95
|
|
14
|
Coronin-1 is associated with neutrophil survival and is cleaved during apoptosis: potential implication in neutrophils from cystic fibrosis patients.
|
J Immunol
|
2009
|
0.93
|
|
15
|
Structures of human proteinase 3 and neutrophil elastase--so similar yet so different.
|
FEBS J
|
2010
|
0.93
|
|
16
|
Computational prediction of the binding site of proteinase 3 to the plasma membrane.
|
Proteins
|
2008
|
0.91
|
|
17
|
Targets of anti-endothelial cell antibodies in pulmonary hypertension and scleroderma.
|
Eur Respir J
|
2011
|
0.90
|
|
18
|
Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
|
Ann Rheum Dis
|
2013
|
0.89
|
|
19
|
Nuclear-to-cytoplasmic relocalization of the proliferating cell nuclear antigen (PCNA) during differentiation involves a chromosome region maintenance 1 (CRM1)-dependent export and is a prerequisite for PCNA antiapoptotic activity in mature neutrophils.
|
J Biol Chem
|
2012
|
0.86
|
|
20
|
Immune system dysregulation in uremia: role of oxidative stress.
|
Blood Purif
|
2002
|
0.86
|
|
21
|
Proteomes of umbilical vein and microvascular endothelial cells reflect distinct biological properties and influence immune recognition.
|
Proteomics
|
2012
|
0.85
|
|
22
|
Proteinase-3 induces procaspase-3 activation in the absence of apoptosis: potential role of this compartmentalized activation of membrane-associated procaspase-3 in neutrophils.
|
J Immunol
|
2005
|
0.85
|
|
23
|
Apoptosis-induced proteinase 3 membrane expression is independent from degranulation.
|
J Leukoc Biol
|
2003
|
0.84
|
|
24
|
Myeloperoxidase promoter polymorphism -463G is associated with more severe clinical expression of cystic fibrosis pulmonary disease.
|
Mediators Inflamm
|
2006
|
0.83
|
|
25
|
Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation.
|
J Immunol
|
2012
|
0.83
|
|
26
|
Molecular analysis of the membrane insertion domain of proteinase 3, the Wegener's autoantigen, in RBL cells: implication for its pathogenic activity.
|
J Leukoc Biol
|
2011
|
0.82
|
|
27
|
Cleavage of p21/WAF1/CIP1 by proteinase 3 modulates differentiation of a monocytic cell line. Molecular analysis of the cleavage site.
|
J Biol Chem
|
2005
|
0.81
|
|
28
|
Characterization of cytosolic proliferating cell nuclear antigen (PCNA) in neutrophils: antiapoptotic role of the monomer.
|
J Leukoc Biol
|
2013
|
0.80
|
|
29
|
Targeting cytosolic proliferating cell nuclear antigen in neutrophil-dominated inflammation.
|
Front Immunol
|
2012
|
0.79
|
|
30
|
Apoptosis, cell death and inflammation.
|
J Innate Immun
|
2010
|
0.79
|
|
31
|
Restoring glutathione as a therapeutic strategy in chronic kidney disease.
|
Nephrol Dial Transplant
|
2004
|
0.77
|
|
32
|
Neurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling.
|
Arthritis Res Ther
|
2014
|
0.76
|
|
33
|
Neutrophils in the innate immunity conundrum of cystic fibrosis: a CFTR-related matter?
|
J Innate Immun
|
2013
|
0.75
|
|
34
|
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.
|
J Innate Immun
|
2016
|
0.75
|
|
35
|
[Pathophysiology of ANCA-associated vasculitides].
|
Presse Med
|
2012
|
0.75
|
|
36
|
Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
|
Postgrad Med J
|
2014
|
0.75
|